NDC 55466-110

LEVO-T

Levothyroxine Sodium

LEVO-T is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Neolpharma, Inc.. The primary component is Levothyroxine Sodium.

Product ID55466-110_7963f41b-8068-59bc-e053-2991aa0a582f
NDC55466-110
Product TypeHuman Prescription Drug
Proprietary NameLEVO-T
Generic NameLevothyroxine Sodium
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-10-29
Marketing CategoryNDA / NDA
Application NumberNDA021342
Labeler NameNeolpharma, Inc.
Substance NameLEVOTHYROXINE SODIUM
Active Ingredient Strength125 ug/1
Pharm Classesl-Thyroxine [EPC],Thyroxine [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 55466-110-11

90 TABLET in 1 BOTTLE (55466-110-11)
Marketing Start Date2015-10-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55466-110-19 [55466011019]

LEVO-T TABLET
Marketing CategoryNDA
Application NumberNDA021342
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-11-29

NDC 55466-110-11 [55466011011]

LEVO-T TABLET
Marketing CategoryNDA
Application NumberNDA021342
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-29

Drug Details

Active Ingredients

IngredientStrength
LEVOTHYROXINE SODIUM125 ug/1

OpenFDA Data

SPL SET ID:2085385a-7fe4-5bfe-e054-00144ff88e88
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 892255
  • 966248
  • 892251
  • 966161
  • 966197
  • 966399
  • 966167
  • 966401
  • 966397
  • 966214
  • 966270
  • 966154
  • 966178
  • 892246
  • 966208
  • 966188
  • 966249
  • 966253
  • 966225
  • 966224
  • 966221
  • 966220
  • 966222
  • 966410
    • UPC Code
  • 0312345678906

    • Pharmacological Class

    • l-Thyroxine [EPC]
    • Thyroxine [CS]

    Medicade Reported Pricing

    55466011019 LEVO-T 125 MCG TABLET

    Pricing Unit: EA | Drug Type:

    55466011011 LEVO-T 125 MCG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "LEVO-T" or generic name "Levothyroxine Sodium"

    NDCBrand NameGeneric Name
    55466-109LEVO-TLEVO-T
    55466-108LEVO-TLEVO-T
    55466-114LEVO-TLEVO-T
    55466-106LEVO-TLEVO-T
    55466-104LEVO-TLEVO-T
    55466-115LEVO-TLEVO-T
    55466-111LEVO-TLEVO-T
    55466-112LEVO-TLEVO-T
    55466-113LEVO-TLEVO-T
    55466-105LEVO-TLEVO-T
    55466-107LEVO-TLEVO-T
    55466-110LEVO-TLEVO-T
    0074-3727SynthroidLevothyroxine Sodium
    0074-4341SynthroidLevothyroxine Sodium
    0074-4552SynthroidLevothyroxine Sodium
    0074-5182SynthroidLevothyroxine Sodium
    0074-6594SynthroidLevothyroxine Sodium
    0074-6624SynthroidLevothyroxine Sodium
    0074-7068SynthroidLevothyroxine Sodium
    0074-7069SynthroidLevothyroxine Sodium

    Trademark Results [LEVO-T]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    LEVO-T
    LEVO-T
    85592687 4870965 Live/Registered
    CEDIPROF INC.
    2012-04-09
    LEVO-T
    LEVO-T
    77587347 not registered Dead/Abandoned
    ALARA Pharmaceutical Corporation
    2008-10-07
    LEVO-T
    LEVO-T
    76264471 2633200 Dead/Cancelled
    Mova Pharmaceutical Corporation
    2001-05-30
    LEVO-T
    LEVO-T
    74163892 1811400 Dead/Cancelled
    AMERICAN CYANAMID COMPANY
    1991-05-06
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.